<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Insider Trading Headlines for Tuesday May 1st 2018 | Insider Insights</title>
<link href="http://www.insiderinsights.com/insider-news-headlines/2018-05-01" ></link>
<id>urn:uuid:f1d0de20-de94-5cf5-fd05-8fd291ee702d</id>
<updated>2026-07-25T12:09:12-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>AMGN: SANTOS ESTEBAN (VP,OO) Acquired (JB) 3,155 Shares of AMGEN INC for $0.00 on 4/27</title>
<link href="http://www.insiderinsights.com/company/amgn/amgen-inc/id-3570739" ></link>
<id>urn:uuid:29cd1d86-fff7-2aef-5026-ab8d5d1de04b</id>
<updated>2018-05-01T19:50:08-04:00</updated>
<summary type="html" ><![CDATA[AMGEN INC (AMGN). Recent Price: $376.04. Mkt Cap:203.0B. 10D Vol: 2.3mm]]></summary>
</entry>
<entry>
<title>AMGN: PIACQUAD DAVID (VP,BD) Acquired (JB) 957 Shares of AMGEN INC for $0.00 on 4/27</title>
<link href="http://www.insiderinsights.com/company/amgn/amgen-inc/id-3570712" ></link>
<id>urn:uuid:5e08f681-2a20-c241-ba2f-cba00719e8cf</id>
<updated>2018-05-01T19:22:18-04:00</updated>
<summary type="html" ><![CDATA[AMGEN INC (AMGN). Recent Price: $376.04. Mkt Cap:203.0B. 10D Vol: 2.3mm]]></summary>
</entry>
<entry>
<title>AMGN: PATTON CYNTHIA M (VP,CCO) Acquired (JB) 901 Shares of AMGEN INC for $0.00 on 4/27</title>
<link href="http://www.insiderinsights.com/company/amgn/amgen-inc/id-3570709" ></link>
<id>urn:uuid:1ed2d834-0945-fd14-8c96-703b3857d890</id>
<updated>2018-05-01T19:19:42-04:00</updated>
<summary type="html" ><![CDATA[AMGEN INC (AMGN). Recent Price: $376.04. Mkt Cap:203.0B. 10D Vol: 2.3mm]]></summary>
</entry>
<entry>
<title>AMGN: MELINE DAVID W (VP,CFO) Acquired (JB) 4,508 Shares of AMGEN INC for $0.00 on 4/27</title>
<link href="http://www.insiderinsights.com/company/amgn/amgen-inc/id-3570708" ></link>
<id>urn:uuid:a405cc80-b110-9995-5c6f-15aace8291b2</id>
<updated>2018-05-01T19:15:50-04:00</updated>
<summary type="html" ><![CDATA[AMGEN INC (AMGN). Recent Price: $376.04. Mkt Cap:203.0B. 10D Vol: 2.3mm]]></summary>
</entry>
<entry>
<title>ABT: TILTON GLENN F (DIR) Acquired (JB) 2,945 Shares of ABBOTT LABORATORIES for $0.00 on 4/27</title>
<link href="http://www.insiderinsights.com/company/abt/abbott-laboratories/id-3570704" ></link>
<id>urn:uuid:26352711-450f-bcba-0f8f-17d7e5dd9661</id>
<updated>2018-05-01T19:14:19-04:00</updated>
<summary type="html" ><![CDATA[ABBOTT LABORATORIES (ABT)]]></summary>
</entry>
<entry>
<title>ABT: STRATTON JOHN G (DIR) Acquired (JB) 2,945 Shares of ABBOTT LABORATORIES for $0.00 on 4/27</title>
<link href="http://www.insiderinsights.com/company/abt/abbott-laboratories/id-3570705" ></link>
<id>urn:uuid:26ddaef2-d301-481d-fa84-85654e77d12f</id>
<updated>2018-05-01T19:13:45-04:00</updated>
<summary type="html" ><![CDATA[ABBOTT LABORATORIES (ABT)]]></summary>
</entry>
<entry>
<title>ABT: STARKS DANIEL J (DIR) Acquired (JB) 2,945 Shares of ABBOTT LABORATORIES for $0.00 on 4/27</title>
<link href="http://www.insiderinsights.com/company/abt/abbott-laboratories/id-3570701" ></link>
<id>urn:uuid:96a8907d-5fe7-a0ce-008f-5fda72f7541c</id>
<updated>2018-05-01T19:13:12-04:00</updated>
<summary type="html" ><![CDATA[ABBOTT LABORATORIES (ABT)]]></summary>
</entry>
<entry>
<title>AMGN: JOHNSTON LORI A (VP,HR) Acquired (JB) 2,028 Shares of AMGEN INC for $0.00 on 4/27</title>
<link href="http://www.insiderinsights.com/company/amgn/amgen-inc/id-3570702" ></link>
<id>urn:uuid:397f8c01-1647-f364-6d05-8c517d255a58</id>
<updated>2018-05-01T19:12:56-04:00</updated>
<summary type="html" ><![CDATA[AMGEN INC (AMGN). Recent Price: $376.04. Mkt Cap:203.0B. 10D Vol: 2.3mm]]></summary>
</entry>
<entry>
<title>ABT: SCOTT SAMUEL C III (DIR) Acquired (JB) 2,945 Shares of ABBOTT LABORATORIES for $0.00 on 4/27</title>
<link href="http://www.insiderinsights.com/company/abt/abbott-laboratories/id-3570703" ></link>
<id>urn:uuid:070dd30e-e828-e6cb-9f02-822986ff5641</id>
<updated>2018-05-01T19:12:42-04:00</updated>
<summary type="html" ><![CDATA[ABBOTT LABORATORIES (ABT)]]></summary>
</entry>
<entry>
<title>ABT: OSBORN WILLIAM A (DIR) Acquired (JB) 2,945 Shares of ABBOTT LABORATORIES for $0.00 on 4/27</title>
<link href="http://www.insiderinsights.com/company/abt/abbott-laboratories/id-3570699" ></link>
<id>urn:uuid:68a6ff80-4545-9b60-559e-89075a3442a0</id>
<updated>2018-05-01T19:12:10-04:00</updated>
<summary type="html" ><![CDATA[ABBOTT LABORATORIES (ABT)]]></summary>
</entry>
</feed>